Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | IDO1 | P14902 | 5/20 | 0.35 |
| ▸ | TDO2 | P48775 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26833747 | 0.94 | IDO1 (0.34) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL25663239 | 0.89 | IDO1 (0.35) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL26834174 | 0.88 | NPC1 (0.37) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL25663240 | 0.87 | ALDH1A1 (0.35) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL26834149 | 0.87 | NPC1 (0.49) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL25663242 | 0.86 | RAB9A (0.34) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL24056062 | 0.85 | ALDH1A1 (0.40) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL26423975 | 0.85 | NPC1 (0.38) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL26423979 | 0.85 | NPC1 (0.38) | RAB9ANPC1IDO1TDO2ALDH1A1 | |
| SCHEMBL26833755 | 0.85 | GABRP (0.35) | RAB9ANPC1IDO1TDO2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357188-A1 | PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-11-09 | — | — | US | disclosed |
| US-20230357188-A1 | PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357188-A1 | PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF | AHR, ORAI3, WNT3 | RAB9A 3127/4885NPC1 2396/4885IDO1 187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.